Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01528956|
Recruitment Status : Completed
First Posted : February 8, 2012
Last Update Posted : May 18, 2016
RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research trial studies genes in samples from younger patients with adrenocortical tumor.
|Condition or disease||Intervention/treatment|
|Adrenocortical Carcinoma||Genetic: DNA methylation analysis Genetic: RNA analysis Genetic: gene expression analysis Genetic: nucleic acid sequencing Genetic: polymorphism analysis|
- To perform whole-genome sequencing, deep sequencing, micro RNA analysis, methylation status, copy number variation analysis, and single-nucleotide polymorphisms (SNPs) analysis in pediatric adrenocortical tumors and compare those results to those of the same patient's normal cells.
OUTLINE: Archived tumor and blood samples are analyzed for whole-genome sequencing, deep sequencing, micro RNA , methylation status, copy variation, and single-nucleotide polymorphisms. Results are then compared with patients' normal cells.
|Study Type :||Observational|
|Estimated Enrollment :||10 participants|
|Official Title:||Using New Approaches for Genomics Studies in Pediatric Adrenocortical Tumors: Whole Genome Sequencing; Deep Sequencing; miRNA; methDNA and SNP 6.0|
|Study Start Date :||February 2012|
|Actual Primary Completion Date :||May 2016|
- Identification of genetic factors affecting adrenocortical tumors
- Comprehensive catalog of altered genes in adrenocortical samples
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01528956
|Principal Investigator:||Gerard Zambetti, PhD||St. Jude Children's Research Hospital|